LOINC_NUM
stringlengths
3
8
COMPONENT
stringlengths
2
246
PROPERTY
stringlengths
1
29
TIME_ASPCT
stringlengths
1
15
SYSTEM
stringlengths
1
106
SCALE_TYP
stringclasses
10 values
METHOD_TYP
stringlengths
1
57
CLASS
stringlengths
2
24
CLASSTYPE
int64
1
4
LONG_COMMON_NAME
stringlengths
3
254
SHORTNAME
stringlengths
2
51
EXTERNAL_COPYRIGHT_NOTICE
stringlengths
39
2.6k
STATUS
stringclasses
4 values
VersionFirstReleased
stringlengths
1
7
VersionLastChanged
stringlengths
1
5
9344-3
Coproporphyrin 1/Coproporphyrin.total
MRto
24H
Urine
Qn
null
CHEM
1
Coproporphyrin 1/Coproporphyrin.total [Mass Ratio] in 24 hour Urine
Copro1/Copro total 24h Ur
null
ACTIVE
1.0i
2.7
93443-0
Self-care abilities
Find
Pt
^Patient
Nom
null
CLIN
2
Self-care abilities
Self-care abilities
null
ACTIVE
2.67
2.67
93444-8
Accessibility of home entrance
Find
Pt
^Patient
Nom
null
CLIN
2
Accessibility of home entrance
Access of home entrance
null
ACTIVE
2.67
2.67
93445-5
Accessibility note
Find
Pt
Patient's home
Doc
Nurse
DOC.MISC
2
Accessibility note Patient's home Nurse
Accessibility note Pt's home Nurse
null
ACTIVE
2.67
2.67
93446-3
Accessibility of home interior
Find
Pt
^Patient
Nom
null
CLIN
2
Accessibility of home interior
Access home int
null
ACTIVE
2.67
2.67
93447-1
Home accessibility modification responsible party
Find
Pt
^Patient
Nom
null
CLIN
2
Home accessibility modification responsible party
Home access mod responsible party
null
ACTIVE
2.67
2.67
93448-9
Home accessibility evaluation status
Find
Pt
^Patient
Nom
null
DOC.MISC
2
Home accessibility evaluation status
Home access eval status
null
ACTIVE
2.67
2.67
93449-7
Appointment of legal guardian
Find
Pt
^Patient
Nom
null
ADMIN.PATIENT
2
Appointment of legal guardian
Appt legal guardian
null
ACTIVE
2.67
2.67
9345-0
Coproporphyrin 3
MCnc
Pt
Urine
Qn
null
CHEM
1
Coproporphyrin 3 [Mass/volume] in Urine
Copro3 Ur-mCnc
null
ACTIVE
1.0i
2.73
93450-5
Coagulation factor VIII Inhibitor
ACnc
Pt
PPP
Qn
Chromo
COAG
1
Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method
Fact VIII Inhib PPP Chro-aCnc
null
ACTIVE
2.67
2.67
93451-3
Nor-W-18+Nor-W-15
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Nor-W-18+Nor-W-15 [Mass/volume] in Urine by Confirmatory method
Nor-W-18+Nor-W-15 Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93452-1
W-19
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
W-19 [Mass/volume] in Urine by Confirmatory method
W-19 Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93453-9
W-15
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
W-15 [Mass/volume] in Urine by Confirmatory method
W-15 Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93454-7
W-18
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
W-18 [Mass/volume] in Urine by Confirmatory method
W-18 Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93455-4
IC-26
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
IC-26 [Mass/volume] in Urine by Confirmatory method
IC-26 Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93456-2
MT-45
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
MT-45 [Mass/volume] in Urine by Confirmatory method
MT-45 Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93457-0
AH-8529
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
AH-8529 [Mass/volume] in Urine by Confirmatory method
AH-8529 Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93458-8
AH-8533
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
AH-8533 [Mass/volume] in Urine by Confirmatory method
AH-8533 Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93459-6
U-47700
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
U-47700 [Mass/volume] in Urine by Confirmatory method
U-47700 Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93460-4
AH-7921
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
AH-7921 [Mass/volume] in Urine by Confirmatory method
AH-7921 Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93461-2
4-Methoxybutyrylfentanyl
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
4-Methoxybutyrylfentanyl [Mass/volume] in Urine by Confirmatory method
4-Methbutfentanyl Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93462-0
Norcarfentanil
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Norcarfentanil [Mass/volume] in Urine by Confirmatory method
Norcarfentanil Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93463-8
Ocfentanil
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Ocfentanil [Mass/volume] in Urine by Confirmatory method
Ocfentanil Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93464-6
4-Fluorofentanyl
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
p-Fluorofentanyl [Mass/volume] in Urine by Confirmatory method
4-Fluorofentanyl Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93465-3
3-Methylfentanyl
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
3-Methylfentanyl [Mass/volume] in Urine by Confirmatory method
3-Me-fentanyl Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93466-1
Valerylfentanyl
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Valerylfentanyl [Mass/volume] in Urine by Confirmatory method
Valerylfentanyl Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93467-9
Butyrylfentanyl
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Butyrylfentanyl [Mass/volume] in Urine by Confirmatory method
Butyrylfentanyl Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
9346-8
Lipoprotein.beta
MCnc
Pt
Ser/Plas
Qn
Calculated
CHEM
1
Lipoprotein.beta [Mass/volume] in Serum or Plasma by calculation
LDL SerPl Calc-mCnc
null
ACTIVE
1.0i
2.73
93468-7
Acrylfentanyl
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Acrylfentanyl [Mass/volume] in Urine by Confirmatory method
Acrylfentanyl Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93469-5
4-Fluorobutyrylfentanyl
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
4-Fluorobutyrylfentanyl [Mass/volume] in Urine by Confirmatory method
4-Fluorobutyrylfentanyl Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93470-3
Furanylfentanyl
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Furanylfentanyl [Mass/volume] in Urine by Confirmatory method
Furanylfentanyl Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93471-1
Acetyl norfentanyl
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Acetyl norfentanyl [Mass/volume] in Urine by Confirmatory method
Acetyl norfentanyl Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93472-9
4-Methylphenethylacetylfentanyl
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
4-Methylphenethylacetylfentanyl [Mass/volume] in Urine by Confirmatory method
4-MetPhenEthAcetFentanyl Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93473-7
Beta hydroxythiofentanyl
MCnc
Pt
Urine
Qn
Confirm
DRUG/TOX
1
Beta hydroxythiofentanyl [Mass/volume] in Urine by Confirmatory method
B-OH thiofentanyl Ur Cfm-mCnc
null
ACTIVE
2.67
2.67
93474-5
Synthetic opioids panel
-
Pt
Urine
-
Confirm
PANEL.DRUG/TOX
1
Synthetic opioids panel - Urine by Confirmatory method
Synthetic opioids pnl Ur Cfm
null
ACTIVE
2.67
2.67
93475-2
Busulfan clearance
VRatCnt
Stdy
Plas
Qn
null
DRUG/TOX
1
Busulfan clearance from plasma over study
Busulfan Cl from Plas
null
ACTIVE
2.67
2.67
9347-6
pH.combined acid
LsCnc
Pt
Gast fld
Qn
null
CHEM
1
pH combined acid of Gastric fluid
pH Combined Ac Gast
null
ACTIVE
1.0i
2.42
93476-0
Busulfan
TmSCnc
Stdy
Plas
Qn
null
DRUG/TOX
1
Busulfan [Area under the curve] in Plasma
Busulfan Plas-AUC
null
ACTIVE
2.67
2.67
93477-8
Busulfan given
Mass
XXX
Dose
Qn
null
DRUGDOSE
1
Busulfan given [Mass] of Dose
Busulfan Gvn ?Tm Dose
null
ACTIVE
2.67
2.68
93478-6
Busulfan area under the curve panel
-
Stdy
Plas
Qn
null
PANEL.DRUG/TOX
1
Busulfan area under the curve panel - Plasma
Busulfan AUC Pnl Plas
null
ACTIVE
2.67
2.67
93479-4
Observation interpretation
Imp
Pt
XXX
Nom
null
MISC
1
Observation interpretation
Observation Imp
null
ACTIVE
2.67
2.69
93480-2
Cortisol post corticotropin releasing hormone stimulation panel
-
Pt
Ser/Plas
Qn
null
PANEL.CHAL
1
Cortisol post CRH stimulation panel - Serum or Plasma
Cortisol p CRH stimulation Pnl SerPl
null
ACTIVE
2.67
2.67
93481-0
Cortisol^10M post 1 ug/kg CRH IV
MCnc
Pt
Ser/Plas
Qn
null
CHAL
1
Cortisol [Mass/volume] in Serum or Plasma --10 minutes post 1 ug/kg CRH IV
Cortis 10M p 1 ug/kg CRH IV SerPl-mCnc
null
ACTIVE
2.67
2.67
93482-8
Cortisol^1M pre 1 ug/kg CRH IV
MCnc
Pt
Ser/Plas
Qn
null
CHAL
1
Cortisol [Mass/volume] in Serum or Plasma --1 minute pre 1 ug/kg CRH IV
Cortis 1M pre 1 ug/kg CRH IV SerPl-mCnc
null
ACTIVE
2.67
2.67
93483-6
Cortisol^2M post 1 ug/kg CRH IV
MCnc
Pt
Ser/Plas
Qn
null
CHAL
1
Cortisol [Mass/volume] in Serum or Plasma --2 minutes post 1 ug/kg CRH IV
Cortis 2M p 1 ug/kg CRH IV SerPl-mCnc
null
ACTIVE
2.67
2.67
9348-4
pH.free acid
LsCnc
Pt
Gast fld
Qn
null
CHEM
1
pH free acid of Gastric fluid
pH Free Ac Gast
null
ACTIVE
1.0i
2.73
93484-4
Cortisol^5M pre 1 ug/kg CRH IV
MCnc
Pt
Ser/Plas
Qn
null
CHAL
1
Cortisol [Mass/volume] in Serum or Plasma --5 minutes pre 1 ug/kg CRH IV
Cortis 5M pre 1 ug/kg CRH IV SerPl-mCnc
null
ACTIVE
2.67
2.67
93485-1
Columbia - suicide severity rating scale - very young child or cognitively impaired - lifetime recent
-
Pt
^Patient
-
C-SSRS
PANEL.SURVEY.CSSRS
4
Columbia - suicide severity rating scale - very young child or cognitively impaired - lifetime recent [C-SSRS]
null
© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission
ACTIVE
2.67
2.68
93486-9
Has subject engaged in self-injurious behavior, intent unknown
Find
3Mo
^Patient
Ord
null
SURVEY.CSSRS
4
Has subject engaged in self-injurious behavior, intent unknown 3 months
null
null
ACTIVE
2.67
2.67
93487-7
Has subject engaged in self-injurious behavior, intent unknown
Find
Lifetime
^Patient
Ord
null
SURVEY.CSSRS
4
Has subject engaged in self-injurious behavior, intent unknown Lifetime
null
null
ACTIVE
2.67
2.67
93488-5
Guanidinoacetate
SCnc
Pt
Bld.dot
Qn
null
CHEM
1
Guanidinoacetate [Moles/volume] in DBS
Guanidinoacetate DBS-sCnc
null
ACTIVE
2.67
2.67
93489-3
Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG
PrThr
Pt
Ser/Plas
Ord
CBA IFA
SERO
1
AMPAR2 IgG Ab [Presence] in Serum or Plasma by Cell binding immunofluorescent assay
AMPAR2 IgG SerPl Ql CBA IFA
null
ACTIVE
2.67
2.69
93490-1
Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG
Titr
Pt
Ser/Plas
Qn
IF
SERO
1
AMPAR2 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence
AMPAR2 IgG Titr SerPl IF
null
ACTIVE
2.67
2.67
93491-9
Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG
PrThr
Pt
CSF
Ord
CBA IFA
SERO
1
AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
AMPAR2 IgG CSF Ql CBA IFA
null
ACTIVE
2.67
2.69
9349-2
pH.total acid
LsCnc
Pt
Gast fld
Qn
null
CHEM
1
pH total acid of Gastric fluid
pH Total Ac Gast
null
ACTIVE
1.0i
2.42
93492-7
Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG
Titr
Pt
CSF
Qn
IF
SERO
1
AMPAR2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
AMPAR2 IgG Titr CSF IF
null
ACTIVE
2.67
2.67
93493-5
3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Ab.IgG
ACnc
Pt
Ser
Qn
IA
CHEM
1
3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab [Units/volume] in Serum by Immunoassay
HMGCR IgG Ser IA-aCnc
null
ACTIVE
2.67
2.67
93494-3
Buprenorphine
PrThr
Pt
Urine
Ord
Screen
DRUG/TOX
1
Buprenorphine [Presence] in Urine by Screen method
Buprenorphine Ur Ql Scn
null
ACTIVE
2.67
2.67
93495-0
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine
PrThr
Pt
Urine
Ord
Screen
DRUG/TOX
1
2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Screen method
EDDP Ur Ql Scn
null
ACTIVE
2.67
2.67
93496-8
Nortriptyline
PrThr
Pt
Urine
Ord
Screen
DRUG/TOX
1
Nortriptyline [Presence] in Urine by Screen method
Nortrip Ur Ql Scn
null
ACTIVE
2.67
2.67
93497-6
Moxifloxacin 3.0 ug/mL
Susc
Pt
Isolate
OrdQn
Method for Slow-growing mycobacteria
ABXBACT
1
Moxifloxacin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria
Moxifloxacin 3 ug/mL Islt SlowMyco
null
ACTIVE
2.67
2.67
93498-4
Metabotropic glutamate receptor 1 Ab.IgG
PrThr
Pt
Ser
Ord
CBA IFA
SERO
1
Metabotropic glutamate receptor 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
mGluR1 IgG Ser Ql CBA IFA
null
ACTIVE
2.67
2.69
93499-2
Metabotropic glutamate receptor 1 Ab.IgG
Titr
Pt
Ser
Qn
IF
SERO
1
Metabotropic glutamate receptor 1 IgG Ab [Titer] in Serum by Immunofluorescence
mGluR1 IgG Titr Ser IF
null
ACTIVE
2.67
2.67
93-5
Cefodizime
Susc
Pt
Isolate
OrdQn
Agar diffusion
ABXBACT
1
Cefodizime [Susceptibility] by Disk diffusion (KB)
Cefodizime Islt KB
null
ACTIVE
1.0
2.19
9350-0
Sulfhydryls
PrThr
Pt
Urine
Ord
null
CHEM
1
Sulfhydryls [Presence] in Urine
Sulfhydryls Ur Ql
null
ACTIVE
1.0i
2.56
93500-7
Metabotropic glutamate receptor 1 Ab.IgG
PrThr
Pt
CSF
Ord
CBA IFA
SERO
1
Metabotropic glutamate receptor 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
mGluR1 IgG CSF Ql CBA IFA
null
ACTIVE
2.67
2.69
93501-5
Metabotropic glutamate receptor 1 Ab.IgG
Titr
Pt
CSF
Qn
IF
SERO
1
Metabotropic glutamate receptor 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
mGluR1 IgG Titr CSF IF
null
ACTIVE
2.67
2.67
93502-3
N-methyl-D-aspartate receptor subunit 1 Ab.IgG
PrThr
Pt
CSF
Ord
CBA IFA
SERO
1
NMDAR subunit 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
NMDAR1 IgG CSF Ql CBA IFA
null
ACTIVE
2.67
2.69
93503-1
N-methyl-D-aspartate receptor subunit 1 Ab.IgG
PrThr
Pt
Ser
Ord
CBA IFA
SERO
1
NMDAR subunit 1 IgG Ab [Presence] in Serum by Cell binding immunofluorescent assay
NMDAR1 IgG Ser Ql CBA IFA
null
ACTIVE
2.67
2.69
93504-9
Cholesterol crystals
PrThr
Pt
Calculus
Ord
XR diffraction
CHEM
1
Cholesterol crystals [Presence] in Stone by X-ray diffraction
Cholest Cry Stone Ql XR diff
null
ACTIVE
2.67
2.67
93505-6
Heptacarboxylporphyrin I
SRat
24H
Urine
Qn
null
CHEM
1
Heptacarboxylporphyrin I [Moles/time] in 24 hour Urine
Hepta-CP I 24h Ur-sRate
null
ACTIVE
2.67
2.67
93506-4
Heptacarboxylporphyrin III
SRat
24H
Urine
Qn
null
CHEM
1
Heptacarboxylporphyrin III [Moles/time] in 24 hour Urine
Hepta-CP3 24h Ur-sRate
null
ACTIVE
2.67
2.67
93507-2
Hexacarboxylporphyrin I
SRat
24H
Urine
Qn
null
CHEM
1
Hexacarboxylporphyrin I [Moles/time] in 24 hour Urine
Hexa-CP I 24h Ur-sRate
null
ACTIVE
2.67
2.67
93508-0
Hexacarboxylporphyrin III
SRat
24H
Urine
Qn
null
CHEM
1
Hexacarboxylporphyrin III [Moles/time] in 24 hour Urine
Hexa-CPr3 24h Ur-sRate
null
ACTIVE
2.67
2.67
93509-8
Pentacarboxylporphyrin I
SRat
24H
Urine
Qn
null
CHEM
1
Pentacarboxylporphyrin I [Moles/time] in 24 hour Urine
Penta-CPI 24h Ur-sRate
null
ACTIVE
2.67
2.67
93510-6
Pentacarboxylporphyrin III
SRat
24H
Urine
Qn
null
CHEM
1
Pentacarboxylporphyrin III [Moles/time] in 24 hour Urine
Penta-CP3 24h Ur-sRate
null
ACTIVE
2.67
2.67
93511-4
Rickettsia rickettsii & Coxiella burnetii phase 1 & Coxiella burnetii phase 2 Ab.IgG panel
-
Pt
Ser
-
null
PANEL.MICRO
1
Rickettsia rickettsii and Coxiella burnetii phase 1 and Coxiella burnetii phase 2 IgG panel - Serum
R. rickettsii + C. burnetii 1 2 IgG Pnl
null
ACTIVE
2.67
2.67
9351-8
ALPRAZolam
PrThr
Pt
Urine
Ord
null
DRUG/TOX
1
ALPRAZolam [Presence] in Urine
Alpraz Ur Ql
null
ACTIVE
1.0i
2.73
9352-6
Amphetamines
MCnt
Pt
Hair
Qn
null
DRUG/TOX
1
Amphetamines [Mass/mass] in Hair
Amphetamines Hair-mCnt
null
ACTIVE
1.0i
2.73
9353-4
Baclofen
MCnc
Pt
Ser/Plas
Qn
null
DRUG/TOX
1
Baclofen [Mass/volume] in Serum or Plasma
Baclofen SerPl-mCnc
null
ACTIVE
1.0i
2.73
9354-2
Benztropine
MCnc
Pt
Urine
Qn
null
DRUG/TOX
1
Benztropine [Mass/volume] in Urine
Benztropine Ur-mCnc
null
ACTIVE
1.0i
2.7
9355-9
Bumetanide
MCnc
Pt
Ser/Plas
Qn
null
DRUG/TOX
1
Bumetanide [Mass/volume] in Serum or Plasma
Bumetanide SerPl-mCnc
null
ACTIVE
1.0i
2.7
9356-7
busPIRone
MCnc
Pt
Ser/Plas
Qn
null
DRUG/TOX
1
busPIRone [Mass/volume] in Serum or Plasma
busPIRone SerPl-mCnc
null
ACTIVE
1.0i
2.73
935-7
Blood product unit expiration
TmStp
Pt
^BPU
Qn
null
BLDBK
1
Blood product unit expiration [Date and time]
BPU Expire Date BPU
null
ACTIVE
1.0
2.73
9357-5
Disulfiram
MCnc
Pt
Urine
Qn
null
DRUG/TOX
1
Disulfiram [Mass/volume] in Urine
Disulfiram Ur-mCnc
null
ACTIVE
1.0i
2.73
9358-3
Lithium
MCnc
Pt
Saliva
Qn
null
DRUG/TOX
1
Lithium [Mass/volume] in Saliva (oral fluid)
Lithium Sal-mCnc
null
ACTIVE
1.0i
2.73
9359-1
Tacrine
MCnc
Pt
Ser/Plas
Qn
null
DRUG/TOX
1
Tacrine [Mass/volume] in Serum or Plasma
Tacrine SerPl-mCnc
null
ACTIVE
1.0i
2.73
93598-1
Intensity of ideation
-
Pt
^Patient
-
C-SSRS.PCI
PANEL.SURVEY.CSSRS
4
Intensity of ideation [C-SSRS.PCI]
null
© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission
ACTIVE
2.67
2.67
93599-9
Frequency of most severe suicidal ideation
Find
1Mo
^Patient
Ord
C-SSRS.PCI
SURVEY.CSSRS
4
Frequency of most severe suicidal ideation 1 month [C-SSRS.PCI]
null
© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission
ACTIVE
2.67
2.67
93600-5
Frequency of most severe suicidal ideation
Find
Lifetime
^Patient
Ord
C-SSRS.PCI
SURVEY.CSSRS
4
Frequency of most severe suicidal ideation Lifetime [C-SSRS.PCI]
null
© 2008 Research Foundation of Mental Hygiene, Inc. Used with permission
ACTIVE
2.67
2.67
93603-9
Multisection^WO & W contrast IV
Find
Pt
Head & Neck>Spine.cervical
Doc
CT
RAD
2
CT Head and Cervical spine WO and W contrast IV
CT Head+C-spine WO+W contr IV
null
ACTIVE
2.67
2.67
93604-7
Multisection
Find
Pt
Lower extremity.bilateral>Lower extremity arteries+Lower extremity veins
Doc
US.doppler
RAD
2
US.doppler Lower extremity arteries+veins - bilateral
DOP LE aa+vv-Bl
null
ACTIVE
2.67
2.67
93605-4
Views 2 or 3
Find
Pt
Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx
Doc
XR
RAD
2
XR Skull to Coccyx 2 or 3 Views
XR Skull to Coccyx 2V or 3V
null
ACTIVE
2.67
2.67
93606-2
Views 4 or 5
Find
Pt
Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx
Doc
XR
RAD
2
XR Skull to Coccyx 4 or 5 Views
XR Skull to Coccyx 4V or 5V
null
ACTIVE
2.67
2.67
93607-0
Views GE 6
Find
Pt
Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx
Doc
XR
RAD
2
XR Skull to Coccyx GE 6 Views
XR Skull to Coccyx GE 6V
null
ACTIVE
2.67
2.67
93608-8
Atrial contraction strain rate.max
ARat
Pt
Heart.ventricle.left
Qn
US.3D
CARD.US
2
Left ventricular Maximum atrial contraction strain rate by US 3D
LV Max atrial contract strain rate 3D US
null
ACTIVE
2.67
2.67
9360-9
Bartonella quintana Ab.IgG
Titr
Pt
Ser
Qn
null
MICRO
1
Bartonella quintana IgG Ab [Titer] in Serum
B quintana IgG Titr Ser
null
ACTIVE
1.0i
2.73
93609-6
Atrial contraction strain rate.circumferential.max
LenRto
Pt
Heart.ventricle.left
Qn
US.3D
CARD.US
2
Left ventricular Maximum circumferential atrial contraction strain rate by US 3D
LV Max circ atrial contract st rt 3D US
null
ACTIVE
2.67
2.67
93610-4
Atrial contraction strain rate.longitudinal.max
ARat
Pt
Heart.ventricle.left
Qn
US.3D
CARD.US
2
Left ventricular Maximum longitudinal atrial contraction strain rate by US 3D
LV Max long atrial contract str rt 3D US
null
ACTIVE
2.67
2.67
93611-2
Circumferential strain rate.early diastole.max
ARat
Pt
Heart.ventricle.left
Qn
US.3D
CARD.US
2
Left ventricular Maximum circumferential strain rate during early diastole by US 3D
LV Max circ strain rate early dias 3D US
null
ACTIVE
2.67
2.67